RESUMO
The gene for ataxia-telangiectasia, ATM, spans about 150 kb of genomic DNA. ATM mutations are found along the entire gene, with no evidence of a mutational hot spot. Using DNA as the starting material, we screened the ATM gene in 92 A-T patients, using an optimized single-strand conformation polymorphism (SSCP) technique that detected all previously known mutations in the polymerase chain reaction (PCR) segments being analyzed. To expedite screening, we sequentially loaded the SSCP gels with three different sets of PCR products that were pretested to avoid overlapping patterns. Many of the DNA changes we detected were intragenic polymorphisms. Of an expected 177 unknown mutations, we detected approximately 70%, mostly protein truncating mutations (that would have been detectable by protein truncation testing if RNA starting material had been available). Mutations have now been defined for every exon of the ATM gene. Herein, we present 35 new mutations and 34 new intragenic polymorphisms or rare variants within the ATM gene. This is the most comprehensive compilation of ATM polymorphisms assembled to date. Defining polymorphic sites as well as mutations in the ATM gene will be of great importance in designing automated methods for detecting mutations.
Assuntos
Ataxia Telangiectasia/genética , Mutação , Polimorfismo Genético , Proteínas Serina-Treonina Quinases , Proteínas/genética , Proteínas Mutadas de Ataxia Telangiectasia , Proteínas de Ciclo Celular , Análise Mutacional de DNA , Primers do DNA/genética , Proteínas de Ligação a DNA , Etnicidade/genética , Éxons/genética , Técnicas Genéticas , Humanos , Terminação Traducional da Cadeia Peptídica/genética , Polimorfismo Conformacional de Fita Simples , Proteínas Supressoras de Tumor , Estados UnidosRESUMO
We have found a complex repeat sequence (NS22) that is highly polymorphic and located within intron 45 of the ataxia-telangiectasia gene (ATM). Sequencing this region from various individuals demonstrated two different polymorphic repeating units adjacent to one another. The fact that the sequence is located within the ATM gene provides a unique opportunity to follow segregation of affected and unaffected haplotypes for prenatal diagnosis of ataxia-telangiectasia. The high degree of polymorphism observed with this marker will also aid in evaluating loss of heterozygosity (LOH) across this region of the genome and may prove valuable in assessing the role of the ATM gene in susceptibility to cancer.
Assuntos
Repetições de Microssatélites/genética , Polimorfismo Genético/genética , Proteínas Serina-Treonina Quinases , Proteínas/genética , Proteínas Mutadas de Ataxia Telangiectasia , Sequência de Bases , Proteínas de Ciclo Celular , Cromossomos Humanos Par 11/genética , Proteínas de Ligação a DNA , Repetições de Dinucleotídeos/genética , Feminino , Humanos , Perda de Heterozigosidade/genética , Masculino , Dados de Sequência Molecular , Linhagem , Análise de Sequência de DNA , Proteínas Supressoras de TumorRESUMO
Ataxia telangiectasia (A-T) is an autosomal recessive disorder with a broad range of clinical manifestations and a frequency of 1:40,000-100,000 live births. Epidemiological studies have suggested that A-T heterozygotes are at an elevated risk of breast cancer. ATM mutations occur worldwide over the entire ATM gene, making it difficult to identify heterozygotes in large populations. However, some founder-effect mutations are specific for certain populations. Here, we present four mutations in Costa Rican A-T patients that accounted for 86-93% of 41 patients studied in two batches. We have developed assays for rapid detection of these four mutations which can be used diagnostically. They will also enable the Costa Rican population to be used as a model for analyzing the role of ATM heterozygosity in cancer development and other disorders.
Assuntos
Ataxia Telangiectasia/genética , Efeito Fundador , Triagem de Portadores Genéticos , Testes Genéticos/métodos , Haplótipos , Ataxia Telangiectasia/diagnóstico , Códon de Terminação , Costa Rica , Éxons/genética , Genes Recessivos , Humanos , Mutação Puntual , Mapeamento por Restrição , Deleção de SequênciaRESUMO
Two regions of the genome contain members of the MAGE gene family; Xq27-qter and Xp21.3. We isolated a transcript, MAGE Xp-2, by screening a cDNA library from the human epithelial carcinoma cell line, HEp-2, using autoantibodies from patients with systemic lupus erythematosus (SLE). The open reading frame (ORF) of MAGE Xp-2 is entirely contained in exon 4, a signature feature of the MAGE gene family. While MAGE Xp-2 shares genomic homology with MAGE Xp-1, the predicted proteins are quite divergent. Specific primers were designed to reliably distinguish between MAGE Xp-1 and MAGE Xp-2 expression. MAGE Xp-2 is expressed in testis, but not in other normal tissues. It is also expressed strongly in two of seven melanoma cell lines and one of four breast carcinomas. MAGE gene expression may be important not only for tumor recognition and cancer therapy, but, because it is the apparent target of autoantibodies in SLE sera, it may also play a role in autoimmune diseases.
Assuntos
Expressão Gênica , Imunoproteínas/genética , Lúpus Eritematoso Sistêmico/imunologia , Proteínas/química , Proteínas/genética , Sequência de Aminoácidos , Antígenos de Neoplasias/química , Antígenos de Neoplasias/genética , Autoanticorpos/genética , Autoanticorpos/imunologia , Sequência de Bases , Northern Blotting , Mapeamento Cromossômico , DNA Complementar , Éxons , Biblioteca Gênica , Humanos , Imunoproteínas/química , Imunoproteínas/imunologia , Íntrons , Dados de Sequência Molecular , Proteínas de Neoplasias/química , Neoplasias/genética , Proteínas/imunologia , Análise de Sequência , Células Tumorais Cultivadas , Cromossomo XRESUMO
We used a single-cell alkaline gel electrophoresis (SCAGE) assay to study repair of primarily single-stranded DNA breaks after in vitro exposure to ionizing radiation in cells from children with systemic lupus erythematosus (SLE), juvenile rheumatoid arthritis (JRA), systemic sclerosis (SSc) and dermatomyositis. Peripheral blood lymphocytes from patients with SLE, JRA and SSc had significantly greater DNA damage after irradiation with 1.5 Gy and 30 min incubation (i.e. repair time) than did those from controls, as assessed by the length of the migrating DNA comet. The mean comet tail lengths were: SLE, 42 microns; JRA, 40 microns; and SSc, 36 microns. Each of these was significantly different from controls, which had a mean comet tail length of 18 microns (P < 0.001, < 0.001 and < 0.05, respectively). Cells from patients with dermatomyositis had an average comet tail length of 22 microns and were not significantly different from controls. Understanding the etiology of the delay in DNA repair in these diseases may provide insight into disease pathogenesis.